CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-04 | Johnson Bankole A. Chief Medical Officer | Sale | −200,000 | 148,246 | ||
| 2021-04-06 | Johnson Bankole A. Chief Medical Officer | Sale | −150,000 | $2.50 | $375K | 548,336 |
| 2020-08-20 | Johnson Bankole A. Chief Medical Officer | Sale | −350,000 | $1.21 | $424K | 1,055 |
| 2019-12-12 | Johnson Bankole A. Chief Medical Officer | Sale | −150,000 | $1.00 | $150K | 698,336 |
Page 1 of 1 · 4 trades